We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GFL icon
276
GFL Environmental
GFL
$15B
$19.4K ﹤0.01%
500
– –
LUV icon
277
Southwest Airlines
LUV
$23B
$18.8K ﹤0.01%
519
– –
VO icon
278
Vanguard Morningstar Mid-Cap ETF
VO
$108B
$18.7K ﹤0.01%
340
– –
OXY.WS icon
279
Occidental Petroleum Corp Warrants
OXY.WS
$32.2B
$18.7K ﹤0.01%
500
– –
VIG icon
280
Vanguard Dividend Appreciation ETF
VIG
$114B
$18.4K ﹤0.01%
113
– –
CI icon
281
Cigna
CI
$72.7B
$18.2K ﹤0.01%
65
– –
HRB icon
282
H&R Block
HRB
$5.82B
$18.2K ﹤0.01%
570
– –
FTXN icon
283
First Trust Nasdaq Oil & Gas ETF
FTXN
$159M
$17.9K ﹤0.01%
680
-5,045
-88% -$133K
SPG icon
284
Simon Property Group
SPG
$71.9B
$17.9K ﹤0.01%
155
– –
ADX icon
285
Adams Diversified Equity Fund
ADX
$3.17B
$17.8K ﹤0.01%
1,057
– –
VGT icon
286
Vanguard Information Technology ETF
VGT
$147B
$17.7K ﹤0.01%
320
– –
RIG icon
287
Transocean
RIG
$5.71B
$17.5K ﹤0.01%
2,500
– –
INCO icon
288
Columbia India Consumer ETF
INCO
$236M
$17.3K ﹤0.01%
330
– –
ELV icon
289
Elevance Health
ELV
$84.9B
$16.4K ﹤0.01%
37
– –
VB icon
290
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
$15.9K ﹤0.01%
80
– –
DJTWW
291
Trump Media & Technology Group Warrants
DJTWW
$820M
$15.9K ﹤0.01%
6,100
– –
BNY
292
Bank of New York Mellon
BNY
$108B
$15.8K ﹤0.01%
355
– –
BWIN
293
Baldwin Insurance Group
BWIN
$2.77B
$15.6K ﹤0.01%
630
+190
+43% +$4.5K
SHAK icon
294
Shake Shack
SHAK
$2.83B
$15.5K ﹤0.01%
200
– –
GEHC icon
295
GE HealthCare
GEHC
$31.8B
$15.4K ﹤0.01%
189
– –
CMCSA icon
296
Comcast
CMCSA
$89.3B
$14.3K ﹤0.01%
+345
New +$13.7K
AZN icon
297
AstraZeneca
AZN
$250B
$14.3K ﹤0.01%
100
– –
FSLR icon
298
First Solar
FSLR
$26.2B
$14.3K ﹤0.01%
75
– –
NOC icon
299
Northrop Grumman
NOC
$80.7B
$13.7K ﹤0.01%
30
+20
+200% +$9.07K
RPM icon
300
RPM International
RPM
$14.8B
$13.5K ﹤0.01%
150
– –
10 11
12
13 14

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.